Breaking News

PTI Appoints Tech Transfer Director

April 8, 2014

Cox to oversee commercialization activities for the transfer of technology

Bryan Cox has been promoted to director of Technology Transfer at Pharma Tech Industries (PTI). Mr. Cox will oversee all commercialization activities for the transfer of technology and integration of new customers at all of the company’s manufacturing sites. Mr. Cox previously served as plant manager of the company’s primary facility in Royston, GA. He joined the company in October 2010 as a staff engineer.
The company recently expanded its on-site testing capabilities at its Royston plant with a new analytical lab for both Rx and OTC drugs. The company is also expanding its production facility in Union, MO, with approximately 60,000 sq.-ft. of additional manufacturing space, which will be used primarily for the production of ingestible powders and will include a production room built to ISO8/100,000 clean room standards. The project is scheduled to be completed in 4Q14.
“During his tenure with Pharma Tech Industries, Byran has consistently demonstrated success managing a diverse roster of projects effectively,” said Tee Noland, chairman of Pharma Tech Industries.  “As PTI continues to add new services and take on new customers, Bryan will play an instrumental role in leading the technological transfer process to ensure flawless execution during the hand off between sales and commercial production.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important